1. Home
  2. ATNM vs INLX Comparison

ATNM vs INLX Comparison

Compare ATNM & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATNM
  • INLX
  • Stock Information
  • Founded
  • ATNM 2000
  • INLX 1996
  • Country
  • ATNM United States
  • INLX United States
  • Employees
  • ATNM N/A
  • INLX 199
  • Industry
  • ATNM Biotechnology: Pharmaceutical Preparations
  • INLX EDP Services
  • Sector
  • ATNM Health Care
  • INLX Technology
  • Exchange
  • ATNM Nasdaq
  • INLX Nasdaq
  • Market Cap
  • ATNM 56.5M
  • INLX 59.0M
  • IPO Year
  • ATNM N/A
  • INLX N/A
  • Fundamental
  • Price
  • ATNM $1.22
  • INLX $13.70
  • Analyst Decision
  • ATNM Strong Buy
  • INLX
  • Analyst Count
  • ATNM 5
  • INLX 0
  • Target Price
  • ATNM $10.20
  • INLX N/A
  • AVG Volume (30 Days)
  • ATNM 319.6K
  • INLX 4.3K
  • Earning Date
  • ATNM 11-14-2024
  • INLX 11-13-2024
  • Dividend Yield
  • ATNM N/A
  • INLX N/A
  • EPS Growth
  • ATNM N/A
  • INLX N/A
  • EPS
  • ATNM N/A
  • INLX N/A
  • Revenue
  • ATNM $81,000.00
  • INLX $17,930,991.00
  • Revenue This Year
  • ATNM $186.10
  • INLX $9.27
  • Revenue Next Year
  • ATNM $19,248.94
  • INLX $8.10
  • P/E Ratio
  • ATNM N/A
  • INLX N/A
  • Revenue Growth
  • ATNM N/A
  • INLX 7.17
  • 52 Week Low
  • ATNM $1.16
  • INLX $4.52
  • 52 Week High
  • ATNM $10.24
  • INLX $16.50
  • Technical
  • Relative Strength Index (RSI)
  • ATNM 35.90
  • INLX 49.53
  • Support Level
  • ATNM $1.16
  • INLX $13.49
  • Resistance Level
  • ATNM $1.29
  • INLX $14.38
  • Average True Range (ATR)
  • ATNM 0.09
  • INLX 0.57
  • MACD
  • ATNM 0.00
  • INLX -0.07
  • Stochastic Oscillator
  • ATNM 21.54
  • INLX 47.96

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document strategy to convert documents from one medium to another.

Share on Social Networks: